InspireMD Inc. short interest in 2024
In 2024, InspireMD Inc.'s disclosed short interest ran from 0.44% of shares outstanding on 12 Jan 2024 to 0.65% on 31 Dec 2024, a change of +0.21 percentage points. The year's high was 0.76% on 15 Nov 2024 and its low 0.17% on 13 Sep 2024, averaging 0.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.88 days on 15 Jul 2024. Full history: InspireMD Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.44% (12 Jan 2024)
- End of year
- 0.65% (31 Dec 2024)
- Change
- +0.21 pp
- High
- 0.76% (15 Nov 2024)
- Low
- 0.17% (13 Sep 2024)
- Average
- 0.37%
- Highest days to cover
- 9.88 (15 Jul 2024)
- SEC filings marked
- 7
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.44% | 3.16 | |
| 31 Jan 2024 | 0.42% | 3.53 | |
| 15 Feb 2024 | 0.37% | 4.76 | |
| 29 Feb 2024 | 0.39% | 6.65 | |
| 15 Mar 2024 | 0.39% | 3.99 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 0.38% | 2.62 | |
| 15 Apr 2024 | 0.40% | 1.00 | |
| 30 Apr 2024 | 0.29% | 5.15 | |
| 15 May 2024 | 0.25% | 3.89 | 10-Q filed, results (8-K) |
| 31 May 2024 | 0.30% | 3.06 | |
| 14 Jun 2024 | 0.25% | 4.58 | |
| 28 Jun 2024 | 0.37% | 6.10 | |
| 15 Jul 2024 | 0.34% | 9.88 | |
| 31 Jul 2024 | 0.25% | 1.69 | |
| 15 Aug 2024 | 0.18% | 2.75 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 0.19% | 5.76 | |
| 13 Sep 2024 | 0.17% | 4.15 | |
| 30 Sep 2024 | 0.17% | 2.79 | |
| 15 Oct 2024 | 0.17% | 1.87 | |
| 31 Oct 2024 | 0.31% | 4.09 | |
| 15 Nov 2024 | 0.76% | 3.97 | 10-Q filed |
| 29 Nov 2024 | 0.67% | 1.35 | |
| 13 Dec 2024 | 0.67% | 4.94 | |
| 31 Dec 2024 | 0.65% | 7.17 |
See also: InspireMD Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.